MetLife, Inc. $MET Shares Bought by Cwm LLC

Cwm LLC grew its position in MetLife, Inc. (NYSE:METFree Report) by 144.2% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 57,220 shares of the financial services provider’s stock after purchasing an additional 33,788 shares during the period. Cwm LLC’s holdings in MetLife were worth $4,713,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Quaker Wealth Management LLC increased its holdings in MetLife by 198.2% in the 2nd quarter. Quaker Wealth Management LLC now owns 333 shares of the financial services provider’s stock worth $27,000 after buying an additional 672 shares during the period. Evolution Wealth Management Inc. purchased a new stake in shares of MetLife in the 2nd quarter valued at $35,000. MTM Investment Management LLC acquired a new stake in shares of MetLife in the second quarter worth $37,000. GFG Capital LLC purchased a new position in shares of MetLife during the second quarter worth $38,000. Finally, Abound Wealth Management raised its holdings in shares of MetLife by 652.3% during the second quarter. Abound Wealth Management now owns 489 shares of the financial services provider’s stock worth $39,000 after purchasing an additional 424 shares during the last quarter. Institutional investors and hedge funds own 94.99% of the company’s stock.

Analysts Set New Price Targets

MET has been the topic of several analyst reports. Mizuho initiated coverage on MetLife in a research report on Monday, December 15th. They set an “outperform” rating and a $101.00 price target on the stock. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of MetLife in a report on Monday. Morgan Stanley set a $101.00 price target on MetLife and gave the company an “overweight” rating in a report on Monday, December 15th. Barclays raised their price objective on shares of MetLife from $93.00 to $98.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 8th. Finally, Wolfe Research upgraded shares of MetLife to a “strong-buy” rating in a research note on Tuesday, September 16th. Two analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, MetLife currently has a consensus rating of “Buy” and a consensus price target of $95.73.

Check Out Our Latest Stock Analysis on MET

MetLife Price Performance

Shares of MetLife stock opened at $78.98 on Thursday. The stock has a market capitalization of $52.04 billion, a P/E ratio of 14.87, a PEG ratio of 0.77 and a beta of 0.76. The business has a 50 day simple moving average of $78.61 and a two-hundred day simple moving average of $78.96. MetLife, Inc. has a 12 month low of $65.21 and a 12 month high of $88.09. The company has a debt-to-equity ratio of 0.54, a current ratio of 0.18 and a quick ratio of 0.18.

MetLife (NYSE:METGet Free Report) last issued its quarterly earnings results on Wednesday, November 5th. The financial services provider reported $2.37 EPS for the quarter, topping the consensus estimate of $2.30 by $0.07. MetLife had a return on equity of 21.00% and a net margin of 5.30%.The firm had revenue of $12.46 billion during the quarter, compared to analysts’ expectations of $18.64 billion. During the same period in the previous year, the business earned $1.95 earnings per share. The firm’s revenue for the quarter was down 5.9% on a year-over-year basis. As a group, analysts predict that MetLife, Inc. will post 9.65 EPS for the current fiscal year.

MetLife Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 9th. Stockholders of record on Tuesday, November 4th were given a $0.5675 dividend. This represents a $2.27 dividend on an annualized basis and a dividend yield of 2.9%. The ex-dividend date was Tuesday, November 4th. MetLife’s dividend payout ratio is 42.75%.

MetLife Profile

(Free Report)

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.

Further Reading

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.